The promise and harms of screening for plasma cell dyscrasias von Mohyuddin, Ghulam Rehman, Chakraborty, Rajshekhar, Scheffer Cliff, Edward R.

Volltext

Pola-R-CHP for DLBCL: cost-effective at first glance von Cliff, Edward R. Scheffer, Pandya, Ankur

Volltext

The Double-Edged Sword of Extremely High Prices for Gene Therapies in Sickle Cell Disease von Cliff, Edward R. Scheffer, Tessema, Frazer A

Volltext

Cell-of-origin effect of polatuzumab vedotin in diffuse large B-cell lymphoma: no ordinary subgroup analysis von Russler-Germain, David A, Cliff, Edward R Scheffer, Bartlett, Nancy L

Volltext

Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated Approval von Liu, Ian T T, Kesselheim, Aaron S, Cliff, Edward R Scheffer

Volltext

AI Devices in Neurology—Moving From Diagnosis to Prognosis von Hillis, James M, Cliff, Edward R. Scheffer, Vokinger, Kerstin N

Volltext

Complicated regulatory decision-making following inconsistent trial results: the issue with ibrutinib for mantle cell lymphoma von Cliff, Edward R. Scheffer, Hilal, Talal, Kesselheim, Aaron S.

Volltext

Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease—Estimating the True Value von Cliff, Edward R. Scheffer, Kelkar, Amar H

Volltext

Ensuring Ethical Postprogression Therapy for Patients in Randomized Trial Control Arms von Cliff, Edward R Scheffer, Kesselheim, Aaron S, Feldman, William B

Volltext

Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma von Cliff, Edward R Scheffer, Reynolds, Gemma, Popat, Rakesh, Teh, Benjamin W, Kesselheim, Aaron S, Mohyuddin, Ghulam Rehman

Volltext

Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis von Reynolds, Gemma, Cliff, Edward R. Scheffer, Mohyuddin, Ghulam Rehman, Popat, Rakesh, Midha, Shonali, Liet Hing, Melissa Ng, Harrison, Simon J., Kesselheim, Aaron S., Teh, Benjamin W.

Volltext

Overall survival as a primary end point in multiple myeloma trials von Cliff, Edward R. Scheffer, Mohyuddin, Ghulam Rehman

Volltext

A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy von Cordas dos Santos, David M., Tix, Tobias, Shouval, Roni, Gafter-Gvili, Anat, Alberge, Jean-Baptiste, Cliff, Edward R. Scheffer, Theurich, Sebastian, von Bergwelt-Baildon, Michael, Ghobrial, Irene M., Subklewe, Marion, Perales, Miguel-Angel, Rejeski, Kai

Volltext

Teclistamab in Relapsed or Refractory Multiple Myeloma von Hindié, Elif, Cliff, Edward R. Scheffer, Mian, Hira, Mohyuddin, Ghulam Rehman, Moreau, Philippe, Girgis, Suzette, Goldberg, Jenna D.

Volltext

We must grow the Australian Bone Marrow Donor Registry von Cliff, Edward R. Scheffer, Szer, Jeff

Volltext

Unresolved questions in the second-line use of CAR-T cells for diffuse large B cell lymphoma von Cliff, Edward R. Scheffer, Merryman, Reid W., Armand, Philippe, Jacobson, Caron A.

Volltext

National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval von Cliff, Edward R Scheffer, Rome, Rachel S, Kesselheim, Aaron S, Rome, Benjamin N

Volltext

Should we screen for plasma cell dyscrasias in people with low bone density? von Zhukovsky, Sara, Cliff, Edward R Scheffer, Mohyuddin, Ghulam Rehman

Volltext

The rollercoaster of vaccine-induced immune thrombotic thrombocytopenia von Cliff, Edward R Scheffer

Volltext

Thrombotic complications of immune thrombocytopenic purpura von Qian, Philip, Willcox, Abbey, Cliff, Edward R Scheffer

Volltext